Remove Compounding Remove Diabetes Remove Generic Medicine
article thumbnail

Small molecule API market to value $284.7 billion by 2032

European Pharmaceutical Review

A compound annual growth rate (CAGR) growth of 5.9 The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This is a rise from $162.8 billion in 2022.

article thumbnail

Drug Repurposing: Unlocking access to rare solutions

Express Pharma

Streamlined regulatory pathways One of the biggest enablers of drug repurposing is the regulatory framework designed to expedite approvals for already-approved compounds. For repurposed drugs, early-stage trials such as Phase 1 or 2 might be sufficient, provided there is existing safety data on the compound,” Vyas explains.

article thumbnail

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Quality Matters

Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient. There are also related standards that address a wide range of topics such as packaging, storage and distribution of medicines, the preparation of compounded medicines and prescription labeling.